Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


News Physiol Sci 18: 104-108, 2003; doi:10.1152/nips.01425.2002
1548-9213/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hess, C.
Right arrow Articles by Schifferli, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hess, C.
Right arrow Articles by Schifferli, J. A.
News in Physiological Sciences, Vol. 18, No. 3, 104-108, June 2003
© 2003 Int. Union Physiol. Sci./Am. Physiol. Soc.

Immune Adherence Revisited: Novel Players in an Old Game

Christoph Hess1 and Jürg A. Schifferli2

1 Department of Medicine, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital/Harvard Medical School, Charlestown, Massachusetts 02129; and
2 University Hospital Basel, CH-4031 Basel, Switzerland

Erythrocytes bind immune complexes (ICs) composed of antibodies binding their respective antigen (e.g., bacteria, parasites, viruses, or autoantigen) plus complement proteins via complement receptors [immune adherence (IA)]. In vivo studies have shown that erythrocytes act as an inert shuttle, targeting ICs to fixed macrophages in liver and spleen. Here we outline established and emerging implications of IA in health and disease.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. C. Jacobson and J. H. Weis
Comparative Functional Evolution of Human and Mouse CR1 and CR2
J. Immunol., September 1, 2008; 181(5): 2953 - 2959.
[Full Text] [PDF]


Home page
J. Immunol.Home page
Z. Banki, D. Wilflingseder, C. G. Ammann, M. Pruenster, B. Mullauer, K. Hollander, M. Meyer, G. M. Sprinzl, J. van Lunzen, H.-J. Stellbrink, et al.
Factor I-Mediated Processing of Complement Fragments on HIV Immune Complexes Targets HIV to CR2-Expressing B Cells and Facilitates B Cell-Mediated Transmission of Opsonized HIV to T Cells.
J. Immunol., September 1, 2006; 177(5): 3469 - 3476.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Horakova, O. Gasser, S. Sadallah, J. M. Inal, G. Bourgeois, I. Ziekau, T. Klimkait, and J. A. Schifferli
Complement Mediates the Binding of HIV to Erythrocytes
J. Immunol., September 15, 2004; 173(6): 4236 - 4241.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the Int. Union Physiol. Sci./Am. Physiol. Soc.